ROPINIROLE HYDROCHLORIDE | A090135 | GLENMARK PHARMACEUTICALS LTD
Highest NADAC/Unit
$0.0848
per ea
Lowest NADAC/Unit
$0.0435
per ea
Brand NDCs
0
Generic NDCs
7
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 68462025701ROPINIROLE HCL 3 MG TABLET | $0.0848 | EA | Generic | — | 2026-06-17 |
| 68462025801ROPINIROLE HCL 4 MG TABLET | $0.0804 | EA | Generic | — | 2026-06-17 |
| 68462025901ROPINIROLE HCL 5 MG TABLET | $0.0766 | EA | Generic | — | 2026-06-17 |
| 68462025601ROPINIROLE HCL 2 MG TABLET | $0.0651 | EA | Generic | — | 2026-06-17 |
| 68462025501ROPINIROLE HCL 1 MG TABLET | $0.0520 | EA | Generic | — | 2026-06-17 |
| 68462025301ROPINIROLE HCL 0.25 MG TABLET | $0.0462 | EA | Generic | — | 2026-06-17 |
| 68462025401ROPINIROLE HCL 0.5 MG TABLET | $0.0435 | EA | Generic | — | 2026-06-17 |
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
No patent or exclusivity listings for this strength.